243 related articles for article (PubMed ID: 10602501)
1. Increased expression of p50-NF-kappaB and constitutive activation of NF-kappaB transcription factors during mouse skin carcinogenesis.
Budunova IV; Perez P; Vaden VR; Spiegelman VS; Slaga TJ; Jorcano JL
Oncogene; 1999 Dec; 18(52):7423-31. PubMed ID: 10602501
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers.
Seo SI; Song SY; Kang MR; Kim MS; Oh JE; Kim YR; Lee JY; Yoo NJ; Lee SH
APMIS; 2009 Aug; 117(8):623-8. PubMed ID: 19664134
[TBL] [Abstract][Full Text] [Related]
3. Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3.
Cogswell PC; Guttridge DC; Funkhouser WK; Baldwin AS
Oncogene; 2000 Feb; 19(9):1123-31. PubMed ID: 10713699
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of the transcription factor NF-kappaB during human mononuclear phagocyte differentiation to macrophages and dendritic cells.
Ammon C; Mondal K; Andreesen R; Krause SW
Biochem Biophys Res Commun; 2000 Feb; 268(1):99-105. PubMed ID: 10652220
[TBL] [Abstract][Full Text] [Related]
5. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
Dong QG; Sclabas GM; Fujioka S; Schmidt C; Peng B; Wu T; Tsao MS; Evans DB; Abbruzzese JL; McDonnell TJ; Chiao PJ
Oncogene; 2002 Sep; 21(42):6510-9. PubMed ID: 12226754
[TBL] [Abstract][Full Text] [Related]
6. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
7. [Effects of different nuclear factor kappaB dimers on the survival of immortalized neural progenitor cells].
Gui LL; Zhang CH; Liu ZH; Chen ZJ; Zhu C
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(13):871-5. PubMed ID: 18756949
[TBL] [Abstract][Full Text] [Related]
8. Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma.
Thornburg NJ; Pathmanathan R; Raab-Traub N
Cancer Res; 2003 Dec; 63(23):8293-301. PubMed ID: 14678988
[TBL] [Abstract][Full Text] [Related]
9. Activation of NF-kappaB by Toxoplasma gondii correlates with increased expression of antiapoptotic genes and localization of phosphorylated IkappaB to the parasitophorous vacuole membrane.
Molestina RE; Payne TM; Coppens I; Sinai AP
J Cell Sci; 2003 Nov; 116(Pt 21):4359-71. PubMed ID: 12966164
[TBL] [Abstract][Full Text] [Related]
10. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak MA; Bellas RE; Kim DW; Zanieski GJ; Rogers AE; Traish AM; Sonenshein GE
J Clin Invest; 1997 Dec; 100(12):2952-60. PubMed ID: 9399940
[TBL] [Abstract][Full Text] [Related]
11. Distinct nuclear factor-kappaB/Rel proteins have opposing modulatory effects in glutamate-induced cell death in HT22 cells.
Ishige K; Tanaka M; Arakawa M; Saito H; Ito Y
Neurochem Int; 2005 Dec; 47(8):545-55. PubMed ID: 16183169
[TBL] [Abstract][Full Text] [Related]
12. Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling.
Massoumi R; Chmielarska K; Hennecke K; Pfeifer A; Fässler R
Cell; 2006 May; 125(4):665-77. PubMed ID: 16713561
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
La E; Muga SJ; Locniskar MF; Fischer SM
Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
[TBL] [Abstract][Full Text] [Related]
14. Altered glucocorticoid receptor expression and function during mouse skin carcinogenesis.
Budunova IV; Carbajal S; Kang H; Viaje A; Slaga TJ
Mol Carcinog; 1997 Mar; 18(3):177-85. PubMed ID: 9115588
[TBL] [Abstract][Full Text] [Related]
15. Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection.
Mishra A; Bharti AC; Varghese P; Saluja D; Das BC
Int J Cancer; 2006 Dec; 119(12):2840-50. PubMed ID: 16998793
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-related apoptosis-inducing ligand-mediated activation of mitochondria-associated nuclear factor-kappaB in prostatic carcinoma cell lines.
Guseva NV; Taghiyev AF; Sturm MT; Rokhlin OW; Cohen MB
Mol Cancer Res; 2004 Oct; 2(10):574-84. PubMed ID: 15498932
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma.
Loercher A; Lee TL; Ricker JL; Howard A; Geoghegen J; Chen Z; Sunwoo JB; Sitcheran R; Chuang EY; Mitchell JB; Baldwin AS; Van Waes C
Cancer Res; 2004 Sep; 64(18):6511-23. PubMed ID: 15374962
[TBL] [Abstract][Full Text] [Related]
18. Role of p52 (NF-kappaB2) in LPS tolerance in a human B cell line.
Wedel A; Frankenberger M; Sulski G; Petersmann I; Kuprash D; Nedospasov S; Ziegler-Heitbrock HW
Biol Chem; 1999 Oct; 380(10):1193-9. PubMed ID: 10595582
[TBL] [Abstract][Full Text] [Related]
19. cis-9,trans-11-conjugated linoleic acid down-regulates phorbol ester-induced NF-kappaB activation and subsequent COX-2 expression in hairless mouse skin by targeting IkappaB kinase and PI3K-Akt.
Hwang DM; Kundu JK; Shin JW; Lee JC; Lee HJ; Surh YJ
Carcinogenesis; 2007 Feb; 28(2):363-71. PubMed ID: 16950795
[TBL] [Abstract][Full Text] [Related]
20. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
